Bruce E. McNutt

423 total citations
15 papers, 324 citations indexed

About

Bruce E. McNutt is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Nephrology. According to data from OpenAlex, Bruce E. McNutt has authored 15 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 4 papers in Nephrology. Recurrent topics in Bruce E. McNutt's work include Electrolyte and hormonal disorders (4 papers), Renal function and acid-base balance (3 papers) and Biomedical and Chemical Research (3 papers). Bruce E. McNutt is often cited by papers focused on Electrolyte and hormonal disorders (4 papers), Renal function and acid-base balance (3 papers) and Biomedical and Chemical Research (3 papers). Bruce E. McNutt collaborates with scholars based in United States, India and Mexico. Bruce E. McNutt's co-authors include Stephen J. Ruberg, Stan Bukofzer, James K. Woodward, Lemuel A. Moyé, Craig M. Pratt, Jeremy N. Ruskin, Stuart Harris, Joel Morganroth, Bruce M. Prenner and Alfred M. Pheley and has published in prestigious journals such as Journal of the American College of Cardiology, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Bruce E. McNutt

15 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce E. McNutt United States 8 144 80 74 52 46 15 324
Yee Guan Yap United Kingdom 15 671 4.7× 155 1.9× 48 0.6× 16 0.3× 15 0.3× 23 770
Cherian Sebastian United States 12 89 0.6× 32 0.4× 29 0.4× 68 1.3× 28 0.6× 28 412
Kjell Vikenes Norway 9 288 2.0× 55 0.7× 104 1.4× 24 0.5× 19 0.4× 42 433
Laura Fanning Australia 10 161 1.1× 42 0.5× 17 0.2× 11 0.2× 18 0.4× 26 446
Birthe H. Grynne Norway 11 42 0.3× 70 0.9× 55 0.7× 60 1.2× 19 0.4× 24 373
Zhimin Du China 8 105 0.7× 54 0.7× 31 0.4× 21 0.4× 13 0.3× 19 305
Nishant K. Sekaran United States 8 60 0.4× 106 1.3× 40 0.5× 23 0.4× 32 0.7× 19 316
Ali Khavandi United Kingdom 8 178 1.2× 61 0.8× 54 0.7× 35 0.7× 12 0.3× 20 314
W Biernacki United Kingdom 10 83 0.6× 117 1.5× 27 0.4× 463 8.9× 16 0.3× 15 682
Kristen A. Hyland United States 7 109 0.8× 70 0.9× 41 0.6× 60 1.2× 8 0.2× 10 386

Countries citing papers authored by Bruce E. McNutt

Since Specialization
Citations

This map shows the geographic impact of Bruce E. McNutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce E. McNutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce E. McNutt more than expected).

Fields of papers citing papers by Bruce E. McNutt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce E. McNutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce E. McNutt. The network helps show where Bruce E. McNutt may publish in the future.

Co-authorship network of co-authors of Bruce E. McNutt

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce E. McNutt. A scholar is included among the top collaborators of Bruce E. McNutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce E. McNutt. Bruce E. McNutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Ananthasubramaniam, Karthik, et al.. (2012). A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease. Journal of Nuclear Cardiology. 19(2). 319–329. 32 indexed citations
3.
Ananthasubramaniam, Karthikeyan, et al.. (2011). A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND TOLERANCE OF REGADENOSON IN PATIENTS WITH RENAL IMPAIRMENT. Journal of the American College of Cardiology. 57(14). E650–E650. 2 indexed citations
4.
Kalra, Sanjay, Shai Efrati, John M. Arthur, et al.. (2011). Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia. American Journal of Health-System Pharmacy. 68(7). 590–598. 7 indexed citations
5.
Koren, Michael J., et al.. (2011). Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia. American Journal of Health-System Pharmacy. 68(9). 818–827. 18 indexed citations
6.
7.
Ghali, Jalal K., Bo Yan, & Bruce E. McNutt. (2008). Conivaptan, a Vasopressin-Receptor Antagonist, for the Treatment of Hyponatremia in Patients with and without Underlying Heart Failure. Journal of Cardiac Failure. 14(6). S73–S73. 4 indexed citations
8.
Verbalis, Joseph G., Steven J. Rosansky, Lynne E. Wagoner, Bruce E. McNutt, & Bo Yan. (2007). EFFICACY AND SAFETY OF CONIVAPTAN, A VASOPRESSIN V1A- AND V2-RECEPTOR ANTAGONIST, DURING PHASE 3 TRIALS OF PATIENTS WITH EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA. CHEST Journal. 132(4). 562B–562B. 1 indexed citations
9.
Weingand, Kurt W., et al.. (1999). TOPICAL HEAT PROVIDES PAIN RELIEF OF DELAYED ONSET MUSCLE SORENESS OF THE DISTAL QUADRICEPS MUSCLES. Medicine & Science in Sports & Exercise. 31(Supplement). S75–S75. 4 indexed citations
10.
Pratt, Craig M., Stephen J. Ruberg, Joel Morganroth, et al.. (1996). Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability. American Heart Journal. 131(3). 472–480. 113 indexed citations
11.
Steinberg, Paul, Bruce E. McNutt, Paul Marshall, et al.. (1996). Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. Journal of Allergy and Clinical Immunology. 97(1). 119–126. 46 indexed citations
12.
Segal, Allen T., et al.. (1993). Safety and efficacy of terfenadine/pseudoephedrine versus clemastine/phenylpropanolamine in the treatment of seasonal allergic rhinitis.. PubMed. 70(5). 389–94. 6 indexed citations
13.
Eller, Mark G., et al.. (1992). Pharmacokinetics of Terfenadine in Healthy Elderly Subjects. The Journal of Clinical Pharmacology. 32(3). 267–271. 13 indexed citations
14.
Eller, Mark G., et al.. (1992). Absence of food effects on the pharmacokinetics of terfenadine. Biopharmaceutics & Drug Disposition. 13(3). 171–177. 4 indexed citations
15.
Spector, S L, Bruce E. McNutt, Roger M. Katz, et al.. (1992). Effect of terfenadine in asthmatic patients.. PubMed. 69(3). 212–6. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yee Guan Yap Breakdown of academic impact, for papers by Cherian Sebastian Breakdown of academic impact, for papers by Kjell Vikenes Breakdown of academic impact, for papers by Laura Fanning Breakdown of academic impact, for papers by Birthe H. Grynne Breakdown of academic impact, for papers by Zhimin Du Breakdown of academic impact, for papers by Nishant K. Sekaran Breakdown of academic impact, for papers by Ali Khavandi Breakdown of academic impact, for papers by W Biernacki Breakdown of academic impact, for papers by Kristen A. Hyland
Rankless by CCL
2026